- Telehealth Visits
- Insurance plan information
Helen Stankiewicz Karita, MD, MS
Infectious Diseases- Telehealth Visits
- Insurance plan information
Helen Stankiewicz Karita, MD, MS
Infectious Diseases- Telehealth Visits
- Insurance plan information
On this page
About me
Education & training
Board certification
- Infectious Disease, American Board of Internal Med/Infectious Disease
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Infectious Diseases, University of Washington School of Medicine
Residency
- Internal Medicine, Advocate Lutheran General Hospital
Internship
- Internal Medicine, Advocate Lutheran General Hospital
Degree
- MD, Universidad Nacional del Nordeste
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 53 reviews
- June 26, 20265 out of 5 Stars
Very caring, concerned, professional, and knowledgeable. I appreciate her explanations of treatment and procedures.
- May 19, 20265 out of 5 Stars
Dr. Helen provides care and treatment at the highest level for her patients. She is thorough, knowledgeable, kind, and attentive. I feel so fortunate to be in her care and the care of the whole clinic is top notch. I cannot thank you all enough.
- May 9, 20265 out of 5 Stars
Doctor Helen is excellent
- March 26, 20265 out of 5 Stars
One of my favorite Dr's. She is so good at what she does and puts you at ease.
- March 19, 20265 out of 5 Stars
Dr. Helen is tops in my book.
- March 10, 20265 out of 5 Stars
Dr. Helen is very thorough in explaining what will happen in the appointment and is extremely easy to talk to about anything.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.